The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completes Oilfield Technology Acquisition

26 May 2015 07:01

RNS Number : 1664O
Highlands Natural Resources PLC
26 May 2015
 

26 May 2105

Highlands Natural Resources ('Highlands' or 'the Company')

Completes Acquisition of a 75% interest in Diversion Technologies' Patents Portfolio

 

Highlands Natural Resources, the London listed oil and gas company, is pleased to announce that the agreement in respect to its all share acquisition of a 75% interest in Diversion Technologies' current patent applications, in the US, UK, Canada and globally, has been signed. These patent applications cover a new well stimulation (fracking) diverter technology known as "DT Ultravert" which the Board believes represents a highly disruptive force in the market, and has the potential to create a transformational shift in the US$50 billion per year fracking industry. The Acquisition will complete on Admission of the new shares.

 

DT Ultravert diverter technology enhances well output by directing hydraulic fracking fluids to unstimulated portions of the formation, thus releasing previously unrecoverable hydrocarbons at a fraction of the cost of drilling a new well. DT Ultravert technology is based on an inert gas form, in contrast with current diverter technologies which are largely based on solid forms.

 

"I believe this IP represents a timely breakthrough that the industry may adopt quickly, and in wide-ranging applications. Its beauty resides in its simplicity and addresses the problem at its source, inside the reservoir."said Diversion Technologies' founder and inventor Paul Mendell.

 

Diversion Technologies (DT) is in licensing discussions with major recognised oilfield service companies pursuing agreements generally structured around DT - and thus Highlands - receiving initial licence fees per oil and gas basin along with retaining royalties on a per use basis. In addition to these initial licensing fees, DT and Highlands will seek royalties of the total fracture stimulation cost per use of the technology.

 

Highlands CEO, Robert B. Price, said, "This transaction has the potential to position Highlands at the forefront of a revolutionary change in the multi-billion dollar fracking industry and accordingly we are delighted to have completed this low cost all share acquisition. In the current oil price environment, the US onshore oil industry is in relative crisis. The need to lower costs is at the top of oil & gas companies' agenda with new technologies being sought to regain competitiveness within the industry on a global basis.

 

"Having recognised the huge revenue potential for this type of diverter process, major oil and gas services companies are prime candidates to license an effective technology to satisfy industry's demand for a breakthrough in fracking and re-fracking techniques. Over the coming months we will be testing DT Ultravert technology on various prospective formations in the US."

 

Acquisition Terms

 

Under the terms of the Highlands / DT agreement, Highlands will acquire 75% of all current and future patent applications filed by DT in exchange for 1,900,000 Highlands' ordinary shares ('the Fee Shares') and 30,000,000 warrants, exercisable at 25p (conditional upon all necessary regulatory approvals and appropriate disclosures or documentation being made to the UKLA). These warrants will be exercisable from three months to three years post completion of the transaction pursuant to the proposed contract.

 

Application has been made for the Fee Shares to be admitted to trading and Admission is expected to become effective and dealings commence at 8.00 a.m. on 29th May 2015 ('Admission'). On Admission, the Company will have 21,988,500 Ordinary Shares in issue. The 21,988,500 Ordinary Shares includes the issue of 98,500 shares to advisers in partial settlement of fees rendered to date.

 

**ENDS**

 

For further information, please visit www.highlandsnr.com, or contact:

 

Robert Price

Highlands Natural Resources plc

+1 (0) 9183617000

Nick Foster

Smithfield Partners

+44 (0) 207 832 0452

Lottie Brocklehurst

St Brides Partners Ltd

+44 (0) 20 7236 1177

Elisabeth Cowell

St Brides Partners Ltd

+44 (0) 20 7236 1177

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUVAARVOAVUUR
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.